Items where authors include "Parmar, MKB"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 8.

Article

Love, SB, Cafferty, F, Snowdon, C et al. (33 more authors) (2022) Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units. Trials, 23 (1). p. 757. ISSN 1745-6215

Parker, CC, James, ND, Brawley, CD et al. (43 more authors) (2022) Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial. PLOS Medicine, 19 (6). e1003998. ISSN 1549-1277

González Martin, A, Oza, AM, Embleton, AC et al. (13 more authors) (2019) Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer. Gynecologic Oncology, 152 (1). pp. 53-60. ISSN 0090-8258

Schoon, J, Brock, IW, Cox, A et al. (7 more authors) (2016) The effect of single nucleotide polymorphisms on clinical outcome and survival in the FOCUS (fluorouracil, oxaliplatin and irinotecan: use and sequencing) clinical trial of metastatic colorectal cancer. Anticancer Research, 36 (12). ABSTR055. pp. 6717-6718. ISSN 0250-7005

Ledermann, JA, Embleton, AC, Raja, F et al. (16 more authors) (2016) Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet, 387 (10023). pp. 1066-1074. ISSN 0140-6736

Oza, AM, Cook, AD, Pfisterer, J et al. (21 more authors) (2015) Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. Lancet Oncology, 16 (8). pp. 928-936. ISSN 1470-2045

Abdel-Rahman, ME, Butler, J, Sydes, MR et al. (9 more authors) (2014) No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials. British Journal of Cancer, 111 (3). pp. 589-597. ISSN 0007-0920

Perren, TJ orcid.org/0000-0001-8472-8856, Swart, AM, Pfisterer, J et al. (23 more authors) (2011) A Phase 3 Trial of Bevacizumab in Ovarian Cancer. New England Journal of Medicine, 365. pp. 2484-2496. ISSN 0028-4793

This list was generated on Sun Mar 24 12:27:05 2024 GMT.